| Authors: |
Citron MP; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States. Electronic address: michael_citron@merck.com., Zang X; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States., Leithead A; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States., Meng S; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States., Rose Ii WA; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States., Murray E; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States., Fontenot J; The University of Louisiana New Iberia Research Center, New Iberia, LA 70560, United States., Bilello JP; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States., Beshore DC; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States., Howe JA; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States. |